4901:TSEFUJIFILM Holdings Corp Analysis
Data as of 2026-03-10 - not real-time
¥3,017.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
FUJIFILM Holdings (4901.T) is trading at ¥3,017, well below its 20‑day (¥3,059), 50‑day (¥3,185) and 200‑day (¥3,315) moving averages, signaling a short‑term bearish momentum confirmed by a bearish MACD and an RSI of 44.3.
Despite the technical weakness, the stock appears significantly undervalued: its PE ratio of 13.4 is less than half the industry average of 29.5, the price‑to‑book of 0.98 is below parity, and the DCF‑derived fair value of ¥3,332 suggests a 34% upside. The company delivers a solid dividend yield of 2.36% with a modest payout ratio of 31%, indicating dividend sustainability even though free cash flow is currently negative. Analyst consensus is “Buy” with median price targets near ¥4,150, reinforcing the upside thesis.
Despite the technical weakness, the stock appears significantly undervalued: its PE ratio of 13.4 is less than half the industry average of 29.5, the price‑to‑book of 0.98 is below parity, and the DCF‑derived fair value of ¥3,332 suggests a 34% upside. The company delivers a solid dividend yield of 2.36% with a modest payout ratio of 31%, indicating dividend sustainability even though free cash flow is currently negative. Analyst consensus is “Buy” with median price targets near ¥4,150, reinforcing the upside thesis.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below key moving averages and bearish MACD
- Support level at ¥2,901 offering downside protection
- High 30‑day volatility (≈30%) despite low beta
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Substantial valuation gap (≈34% upside to DCF fair value)
- Attractive dividend yield with low payout ratio
- Diversified business exposure, especially growing healthcare segment
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strong fundamentals: 5.5% revenue growth, solid operating margins
- Strategic positioning in healthcare and imaging markets
- Consistent analyst support and long‑term upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth5.50%
Profit Margin8.27%
P/E Ratio13.4
ROE7.67%
ROA3.98%
Debt/Equity28.83
P/B Ratio1.0
Op. Cash Flow¥399.6B
Free Cash Flow¥-245679128576
Industry P/E29.5
Technical Analysis
TrendBearish
RSI44.3
Support¥2,901.50
Resistance¥3,268.00
MA 20¥3,058.98
MA 50¥3,185.03
MA 200¥3,314.72
MACDBearish
VolumeStable
Fear & Greed Index78.16
Valuation
Fair Value¥3,332.03
Target Price¥4,059.29
Upside/Downside34.55%
GradeUndervalued
TypeValue
Dividend Yield2.36%
Risk Assessment
Beta0.59
Volatility29.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.